Madrigal Pharmaceuticals (MDGL) Cash & Equivalents (QoQ) (2010 - 2026)
Madrigal Pharmaceuticals (MDGL) Cash & Equivalents (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Madrigal Pharmaceuticals | 16.03 Bn | 15.80 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.26% |
| Dec 31, 2025 | -32.80% |
| Sep 30, 2025 | 58.81% |
| Jun 30, 2025 | 1.39% |
| Mar 31, 2025 | 83.61% |
| Dec 31, 2024 | -57.02% |
| Sep 30, 2024 | -52.95% |
| Jun 30, 2024 | -20.55% |
| Mar 31, 2024 | 523.05% |
| Dec 31, 2023 | 61.01% |
| Sep 30, 2023 | -19.61% |
| Jun 30, 2023 | -31.87% |
| Mar 31, 2023 | -65.82% |
| Dec 31, 2022 | 458.73% |
| Sep 30, 2022 | 11.39% |
| Jun 30, 2022 | 25.99% |
| Mar 31, 2022 | 16.58% |
| Dec 31, 2021 | -26.24% |
| Sep 30, 2021 | 46.61% |
| Jun 30, 2021 | -24.13% |